🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-523861-58-00
Authorised Phase I

A clinical study of MK-6050 in healthy people (MK-6050-001)

2025-523861-58-00 · tracked via the Priya Life Science EU tracker
Sponsor
Merck Sharp & Dohme LLC
Sponsor type
Pharmaceutical company
Therapeutic area
Immune System Diseases
Decision date
12/11/2025
Enrollment target
32
Sites
Belgium

Condition studied

Hidradenitis suppurativa

Eligibility

Age group
18-64 years
Sex
Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-523861-58-00 on CTIS ↗ ← All trials in the EU